Global Liver Institute

To improve the lives of individuals and families impacted by liver disease through promoting innovation, encouraging collaboration, and scaling optimal approaches to help eradicate liver diseases.

Latest from Global Liver Institute

Global Communities Rally around Third Deadliest Cancer – Liver Cancer

October 03, 2023

Article

Global Liver Institute Leads International Program to Build Hope and Raise Awareness during October, Liver Cancer Awareness Month.

We Need You in The Fight Against Liver Cancer, Join #OctoberIs4Livers 2021

October 13, 2021

Article

The GLI LIVE episode with Dr. Sharpless is the first #OctoberIs4Livers activity in a series of engaging and informative global activities taking place throughout the month of October to raise awareness about liver cancer and address the many disparities that exist with this disease.

Global Liver Institute Applauds FDA and CDC Actions to Approve Third COVID-19 Vaccine Dose for Immunocompromised Individuals

August 13, 2021

Article

Global Liver Institute (GLI) CEO and President Donna R. Cryer, JD, today applauded dual actions from U.S. government health agencies.

The Need to Support the Restart of Liver Disease Medical Research and Public Health Programs

May 16, 2021

Article

Few liver health advocacy organizations have policy staff or personnel in Washington, DC. To fill this gap, we provide liver health policy updates to report on timely information and actionable updates on activities relevant to liver health, including liver cancer, viral hepatitis, autoimmune liver conditions as well as issues that span conditions, such as coverage or other policy decisions.

More Vaccines, Fewer Tests: Why COVID-19 Testing Remains Important

May 09, 2021

Article

The COVID-19 Response Program for Patients features information tailored to the special needs of patients living with pediatric liver disease, rare liver disease, NASH, pre/post liver transplant and liver cancer.

Scientific Peer Review of Congressionally Directed Medical Research Programs’ Peer Reviewed Cancer Research Program for the Department of Defense

November 16, 2020

Article

The Congressionally Directed Medical Research Programs’ (CDMRP), Peer Reviewed Cancer Research Program (PRCRP) consumer advocate Steven West recently participated in the evaluation of research applications submitted to the PRCRP.